Orgenesis Stock Price on March 18, 2024

ORGS Stock  USD 0.51  0.02  4.08%   
Below is the normalized historical share price chart for Orgenesis extending back to July 28, 2010. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Orgenesis stands at 0.51, as last reported on the 2nd of June, with the highest price reaching 0.53 and the lowest price hitting 0.46 during the day.
IPO Date
12th of March 2012
200 Day MA
0.5829
50 Day MA
0.56
Beta
1.199
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Orgenesis Stock, it is important to understand the factors that can impact its price. Orgenesis maintains Sharpe Ratio (i.e., Efficiency) of -0.0329, which implies the firm had a -0.0329% return per unit of risk over the last 3 months. Orgenesis exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Orgenesis' Coefficient Of Variation of 10568.08, semi deviation of 9.34, and Risk Adjusted Performance of 0.0152 to confirm the risk estimate we provide.
  
At this time, Orgenesis' Total Stockholder Equity is comparatively stable compared to the past year. Common Stock Shares Outstanding is likely to gain to about 35 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 15.9 M in 2024. . At this time, Orgenesis' Price To Sales Ratio is comparatively stable compared to the past year. Price Sales Ratio is likely to gain to 28.77 in 2024, whereas Price Earnings Ratio is likely to drop (0.28) in 2024. Orgenesis Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0329

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsORGS

Estimated Market Risk

 8.29
  actual daily
73
73% of assets are less volatile

Expected Return

 -0.27
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Orgenesis is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Orgenesis by adding Orgenesis to a well-diversified portfolio.
Price Book
1.3886
Enterprise Value Ebitda
(2.33)
Price Sales
0.6066
Shares Float
27.2 M
Wall Street Target Price
6

Orgenesis Main Headline on 18th of March 2024

GERMANTOWN, Md., March 18, 2024 -- Orgenesis Inc. , a global leader in decentralizing cell and gene therapies , today announced that its CEO, Vered Caplan, will be presenting at the upcoming Bioprocessing Summit Europe. The conference, renowned for gathering leading professionals to advance the manufacturing and quality control of biological and genetic therapies, will take place in Barcelona from March 19th to 21st, 2024. Ms. Ca

Orgenesis Valuation on March 18, 2024

It is possible to determine the worth of Orgenesis on a given historical date. On March 18, 2024 Orgenesis was worth 0.77 at the beginning of the trading date compared to the closed value of 0.88. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Orgenesis stock. Still, in general, we apply an absolute valuation method to find Orgenesis' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Orgenesis where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Orgenesis' related companies.
 Open High Low Close Volume
  0.77    0.84    0.77    0.79    85,336  
03/18/2024
  0.77    0.88    0.77    0.88    40,931  
  0.83    0.88    0.83    0.88    41,218  
Backtest Orgenesis  |  Orgenesis History  |  Orgenesis Valuation   PreviousNext  
Open Value
0.77
0.88
Closing Value
25.65
Upside

Orgenesis Trading Date Momentum on March 18, 2024

On March 19 2024 Orgenesis was traded for  0.88  at the closing time. The top price for the day was 0.88  and the lowest listed price was  0.83 . The trading volume for the day was 41.2 K. The trading history from March 19, 2024 did not cause price change. The trading delta at closing time against the current closing price is 3.41% .

Orgenesis Fundamentals Correlations and Trends

By evaluating Orgenesis' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Orgenesis' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Orgenesis financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Orgenesis Stock history

Orgenesis investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Orgenesis is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Orgenesis will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Orgenesis stock prices may prove useful in developing a viable investing in Orgenesis
Last ReportedProjected for Next Year
Common Stock Shares Outstanding33.4 M35 M
Net Loss-31.6 M-30 M

Orgenesis Stock Technical Analysis

Orgenesis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Orgenesis technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Orgenesis trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Orgenesis Period Price Range

Low
March 18, 2024
0.11  14.29%
High

 0.77 

     

 0.88 

Orgenesis June 2, 2024 Market Strength

Market strength indicators help investors to evaluate how Orgenesis stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Orgenesis shares will generate the highest return on investment. By undertsting and applying Orgenesis stock market strength indicators, traders can identify Orgenesis entry and exit signals to maximize returns

Orgenesis Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Orgenesis' price direction in advance. Along with the technical and fundamental analysis of Orgenesis Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Orgenesis to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Orgenesis is a strong investment it is important to analyze Orgenesis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Orgenesis' future performance. For an informed investment choice regarding Orgenesis Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Orgenesis. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
For more information on how to buy Orgenesis Stock please use our How to Invest in Orgenesis guide.
Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Orgenesis Stock analysis

When running Orgenesis' price analysis, check to measure Orgenesis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orgenesis is operating at the current time. Most of Orgenesis' value examination focuses on studying past and present price action to predict the probability of Orgenesis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orgenesis' price. Additionally, you may evaluate how the addition of Orgenesis to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamental Analysis
View fundamental data based on most recent published financial statements
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Is Orgenesis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Orgenesis. If investors know Orgenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Orgenesis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.33)
Revenue Per Share
0.017
Quarterly Revenue Growth
(0.98)
Return On Assets
(0.42)
Return On Equity
(3.25)
The market value of Orgenesis is measured differently than its book value, which is the value of Orgenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Orgenesis' value that differs from its market value or its book value, called intrinsic value, which is Orgenesis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Orgenesis' market value can be influenced by many factors that don't directly affect Orgenesis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Orgenesis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Orgenesis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Orgenesis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.